Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug3480 | SMS messages Wiki | 1.00 |
| drug1970 | Interleukin 6 (IL6) Antagonist and corticosteroids Wiki | 1.00 |
| drug1969 | Interleukin 6 (IL6) Antagonist Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D016638 | Critical Illness NIH | 0.12 |
| D013577 | Syndrome NIH | 0.09 |
| D045169 | Severe Acute Respiratory Syndrome NIH | 0.04 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
Eggs are well-known to be a balanced source of protein, energy, fatty acids, and micronutrients and increasingly identified as an opportunity to improve nutrition of poor populations. Few implementation studies have been done globally, and none in South Asia, to assess the effectiveness of using behavior change programs to motivate households to increase egg consumption. Egg consumption is particularly poor in Nepal, but the government and development partners are implementing at scale policies and programs to address poor diets and other determinants of undernutrition, which is persistently high in Nepal. This cluster-randomized controlled trial (c-RCT) aims to help address the gap in the evidence base regarding how to improve egg consumption. The c-RCT will evaluate the effectiveness of using short message service (SMS) messaging, layered into a large-scale behavior change program, to improve egg consumption and dietary diversity among children 1 to 2 years of age. A two-arm trial will be used to compare the following two strategies: 1) Suaahara II standard multi-sectoral nutrition interventions without any text messages and 2) Suaahara II standard multi sectoral nutrition interventions plus a SMS message campaign targeting all adult household members of households in the 1000-day period between conception and a child's second birthday.
Description: Change in prevalence of any egg consumption in 24 hours prior to survey among children 12 to 23 months of age.
Measure: Child egg consumption Time: baseline and 12 months laterDescription: Change in prevalence of obtaining minimum dietary diversity score (at least four of seven food groups) in previous 24 hours for children aged 12-23 months of age
Measure: Child minimum dietary diversity Time: baseline and 12 months laterDescription: Change in mean dietary diversity (range:0 lowest - 7 highest) in previous 24 hours for children 12 to 23 months of age
Measure: Child dietary diversity score Time: baseline and 12 months laterDescription: Change in prevalence of any egg consumption in previous 24 hours among adults residing in a household with a child 12 to 23 months of age
Measure: Adult caregiver egg consumption Time: baseline and 12 months laterDescription: Change in prevalence of obtaining minimum dietary diversity score (at least five of ten food groups) in previous 24 hours among adults residing in a household with a child 12 to 23 months of age
Measure: Adult minimum dietary diversity Time: baseline and 12 months laterDescription: Change in mean dietary diversity (range:0 lowest -10 highest) in previous 24 hours for adults residing in a household with a child 12 to 23 months of age
Measure: Adult dietary diversity score Time: baseline and 12 months laterDescription: Change in mean knowledge score (range: 0-8) on core infant and young child feeding practices among adults residing in a household with a child 12 to 23 months of age
Measure: Infant and Young Child Feeding knowledge Time: baseline and 12 months laterDescription: Change in prevalence of any participation in the last 3 months in a Female Community Health Volunteer-led group, by the mother of the survey child 12-23 months of age
Measure: Health Mothers' Groups participation Time: baseline and 12 months laterDescription: Change in number of times participated in the last 3 months in an Female Community Health Volunteer-led group by the mother of the survey child 12-23 months of age
Measure: Health Mothers' Groups participation frequency Time: baseline and 12 months laterDescription: Change in prevalence of any listenership in the last 3 months to Bhanchhin Aama, Suaahara II radio program, in the previous three months by any adult household member
Measure: Adult Bhanchhin Aama listenership Time: baseline and 12 months laterDescription: Change in number of times listened to Bhanchhin Aama, Suaahara II radio program, in the previous three months by any adult household member
Measure: Adult Bhanchhin Aama listenership frequency Time: baseline and 12 months laterAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports